DNA Script Wins ARPA-H Award to Advance DNA Manufacturing

{
  "signal_id": "8a1e7332-0cb8-37c0-d70d-ad552393e0e2",
  "signal_type": "news",
  "signal_subtype": "is_developing",
  "detected_at": "2026-08-06T12:00:42+00:00",
  "company": {
    "name": "GE HealthCare",
    "domain": "gehealthcare.com"
  },
  "data": {
    "url": "https://www.genengnews.com/news/dna-script-wins-arpa-h-award-to-advance-dna-manufacturing/",
    "title": "DNA Script Wins ARPA-H Award to Advance DNA Manufacturing - genengnews.com",
    "excerpt": "DNA Script, in collaboration with GE HealthCare, has been awarded up to $26 million in funding for a four-year initiative from the Advanced Research Projects Agency for Health ( ARPA-H ). The award will support the advancement of the Flexible Automation for Scalable Health ( FLASH ) program, focused on the development of scalable cell-free DNA bioproduction capabilities and powered in part by DNA Script’s enzymatic DNA synthesis (EDS) technology and SYNTAX ® platform. Led by GE HealthCare, the FLASH program aims to develop a modular, automated platform for the rapid, distributed manufacturing of high-fidelity DNA to support research and potential future applications in personalized medicines, vaccines, and other genetic health technologies. DNA Script’s EDS technology supports this goal by enabling faster and more flexible DNA manufacturing workflows. DNA Script, which is contributing its EDS technology and acting as the technical solution integrator for the project, says the company has adapted its solution to incorporate GE HealthCare’s proprietary DNA scaling technology, complementing DNA Script’s EDS technology, with the goal of eventually deploying the integrated platform across U.S. medical research centers, universities, and federal agencies. “ARPA-H solutions are designed to address hard problems with bold, practical approaches,” says John Schiel, program manager...",
    "product": "FLASH program",
    "summary": "GE HealthCare is leading the FLASH program, in collaboration with DNA Script, to develop a modular, automated platform for the rapid, distributed manufacturing of high-fidelity DNA.",
    "planning": true,
    "image_url": "https://www.genengnews.com/wp-content/uploads/2026/08/GettyImages-801095624.jpg",
    "confidence": 0.9,
    "product_data": {
      "name": "FLASH",
      "full_text": "the Flexible Automation for Scalable Health ( FLASH ) program",
      "fuzzy_match": false
    },
    "product_tags": [
      "general_technology",
      "medical"
    ],
    "published_at": "2026-08-06T12:00:42Z",
    "article_sentence": "Led by GE HealthCare, the FLASH program aims to develop a modular, automated platform for the rapid, distributed manufacturing of high-fidelity DNA to support research and potential future applications in personalized medicines, vaccines, and other genetic health technologies.",
    "related_company_name": "DNA Script",
    "related_company_domain": "dnascript.com"
  }
}

curl https://signals.autobound.ai/v1/signals/8a1e7332-0cb8-37c0-d70d-ad552393e0e2 \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"gehealthcare.com","limit":20}'